PTPRC and neoplasm: ITPP treatment induced a clear reduction in the expression of PD‐L1, and to a lesser extent PD‐L2, on the total tumour cell population (Figure 5A,B), as well as on the isolated CD45− cells (Figure 5C,D), and most clearly on the CD45+ immune cell population (Figure 5E,F).